Repository logo
 

Male-Specific Protein Disulphide Isomerase Function is Essential for Plasmodium Transmission and a Vulnerable Target for Intervention.

Accepted version
Peer-reviewed

Change log

Authors

Angrisano, Fiona 
Sala, Katarzyna A 
Tapanelli, Sofia 
Christophides, George K  ORCID logo  https://orcid.org/0000-0002-3323-1687
Blagborough, Andrew M 

Abstract

Inhibiting transmission of Plasmodium is an essential strategy in malaria eradication, and the biological process of gamete fusion during fertilization is a proven target for this approach. Lack of knowledge of the mechanisms underlying fertilization have been a hindrance in the development of transmission-blocking interventions. Here we describe a protein disulphide isomerase essential for malarial transmission (PDI-Trans/PBANKA_0820300) to the mosquito. We show that PDI-Trans activity is male-specific, surface-expressed, essential for fertilization/transmission, and exhibits disulphide isomerase activity which is up-regulated post-gamete activation. We demonstrate that PDI-Trans is a viable anti-malarial drug and vaccine target blocking malarial transmission with the use of PDI inhibitor bacitracin (98.21%/92.48% reduction in intensity/prevalence), and anti-PDI-Trans antibodies (66.22%/33.16% reduction in intensity/prevalence). To our knowledge, these results provide the first evidence that PDI function is essential for malarial transmission, and emphasize the potential of anti-PDI agents to act as anti-malarials, facilitating the future development of novel transmission-blocking interventions.

Description

Keywords

Animals, Antimalarials, Bacitracin, Female, Malaria, Malaria Vaccines, Male, Mice, Plasmodium berghei, Protein Disulfide-Isomerases, Protozoan Proteins

Journal Title

Sci Rep

Conference Name

Journal ISSN

2045-2322
2045-2322

Volume Title

9

Publisher

Springer Science and Business Media LLC

Rights

All rights reserved
Sponsorship
Medical Research Council (MR/N00227X/1)
This work was funded by the MRC (New Investigator Research Grant; award number MR/N00227X/1).